Credit Suisse 31st Annual Healthcare Conference

• Life Sciences
• Infographics

Strategic implications for the 340B Rebate Model Pilot Program

These entities receive discounts on all eligible covered outpatient drugs. The program has expanded substantially over the years, with the number of covered...

• Life Sciences
• CRA Insights

MFN is rewriting the launch planning playbook: Commercial and market access strategies must integrate to succeed

MFN-related uncertainty is reshaping pharmaceutical launch planning by making pricing, sequencing, and forecasting decisions more interconnected and...

• Life Sciences
• Sponsorship & Speaking Engagement

• September 6-8, 2026
• Bangkok, Thailand

ISPOR Asia Pacific Summit 2026

CRA is a proud sponsor of the Educational Symposia session titled “The Oncology Combination Therapy Dilemma: Can Today’s HTA Systems Support Tomorrow’s...

• Damages & Quantum
• Sponsorship & Speaking Engagement

• September 15-16, 2026
• Boston, MA

Pharma & Biotech Patent Litigation Summit North America 2026

CRA is a proud sponsor of the conference. Greg Bell speaks during the session titled “Damages in Pharma & Biotech Litigation:  What Courts are Accepting...